Skip to main content
. Author manuscript; available in PMC: 2014 Dec 15.
Published in final edited form as: Clin Cancer Res. 2013 Oct 16;19(24):6830–6841. doi: 10.1158/1078-0432.CCR-13-0624

Figure 3. PTEN down-regulation is associated with poor prognosis in patients with IPMN.

Figure 3

The survival was calculated by the Kaplan–Meier method comparing patients with normal vs. low PTEN expression. The data show that low PTEN expression is associated with poor survival (Median survival time: PTEN normal= 60.6 months, PTEN low = 48.9 months; p = 0.014, hazard ratio = 6.1). There was no stratification.